Related Experiment Video
Updated: May 28, 2026

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency
Published on: February 2, 2024
Cervical adenocarcinoma: moving towards better prevention
Muhieddine Seoud1, Wiebren A A Tjalma, Veerle Ronsse
1American University of Beirut Medical Center, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Bliss Street, Hamra District, Box: 113-6044/30C, Beirut, Lebanon. mike@aub.edu.lb
Prophylactic human papillomavirus (HPV) vaccination shows promise in preventing cervical adenocarcinoma (ADC), a rising cancer subtype. Vaccination strategies could significantly reduce ADC incidence and impact future cervical cancer prevention efforts.
Area of Science:
- Oncology
- Virology
- Public Health
Background:
- Cervical cancer remains a global health concern, with invasive cervical cancer (ICC) incidence declining due to screening.
- Cervical adenocarcinoma (ADC) incidence is rising, particularly in younger women, contrasting with squamous cell carcinoma (SCC) trends.
- Oncogenic human papillomavirus (HPV) infections are key drivers of cervical cancer, including ADC.
Purpose of the Study:
- To examine the role of oncogenic HPV infections in cervical ADC development and prognosis.
- To analyze the differences between ADC and SCC.
- To evaluate current and future prevention strategies for cervical ADC.
Main Methods:
- Literature review using PubMed, public websites, and congress abstracts.
- Analysis of data on HPV genotypes associated with ADC.
- Evaluation of clinical trial data on HPV vaccine efficacy.
Main Results:
- HPV-16, -18, and -45 are responsible for approximately 90% of global ADC cases, with alpha-7 genotypes (HPV-18, -45) more commonly linked to ADC.
- Increased HPV transmission and challenges in ADC screening may contribute to its rising incidence.
- Current HPV vaccines demonstrate high efficacy against HPV-16/18-related cervical intraepithelial neoplasia and offer broader protection, potentially reducing ADC incidence.
Conclusions:
- Prophylactic HPV vaccination holds significant potential for preventing cervical ADC.
- Vaccination strategies may substantially influence future primary and secondary prevention of cervical cancer.
Related Concept Videos
Cancer Prevention
Some...
Cancer Prevention
Some...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
